Human APP Intracellular Domain Complex with Fe65-PTB2: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Line 34: Line 34:


== APP and Alzheimer disease ==
== APP and Alzheimer disease ==
A&#946; peptides are generated in neuronal secretory vesicles by proteolytic cleavage of the amyloid precursor protein (APP) by proteases, called &#946;-secretase and &#947;-secretase that cleave at the N-terminus and variant C-termini of A&#946; within APP, respectively, resulting in A&#946; of 40 or 42 amino acids (A&#946;40 and A&#946;42, respectively) (Figure 1). Because the N-termini of A&#946;40 and A&#946;42 are identical, development of inhibitors that reduce cleavage of APP at the &#946;-secretase site are likely to be effective for reducing A&#946; peptide forms with alleviation of neurodegeneration and memory deficit. The APP in the vast majority of AD patients possesses the wild-type &#946;-secretase site sequence. <ref>PMID:2654319</ref>
A&#946; peptides are generated in neuronal secretory vesicles by proteolytic cleavage of the amyloid precursor protein (APP) by proteases, called &#946;-secretase and &#947;-secretase that cleave at the N-terminus and variant C-termini of A&#946; within APP, respectively, resulting in A&#946; of 40 or 42 amino acids (A&#946;40 and A&#946;42, respectively)<ref>PMID:2654319</ref>


== References ==
== References ==